Art

J-GLOBAL ID：201702243988752407   Reference number：17A1800784

Improvement in the prognosis of ovarian cancer in the era before addition of molecular targeting therapy

分子標的療法を追加する前の時代の卵巣癌の予後の改善

Author (8)： SHIMADA Takako (National Kyushu Cancer Center, Fukuoka) ,  SAITO Toshiaki (National Kyushu Cancer Center, Fukuoka) ,  SHIMOKAWA Mototsugu (National Kyushu Cancer Center, Fukuoka, JPN) ,  SHIMAMOTO Kumi (National Kyushu Cancer Center, Fukuoka) ,  MATSUSHITA Shuhei (National Kyushu Cancer Center, Fukuoka) ,  YAMAGUCHI Shinichiro (National Kyushu Cancer Center, Fukuoka) ,  ARIYOSHI Kazuya (National Kyushu Cancer Center, Fukuoka) ,  OKADOME Masao (National Kyushu Cancer Center, Fukuoka)
Material： Japanese Journal of Clinical Oncology (Web)  (JJCO (Web))
Volume： 47  Issue： 6  Page： 494-498 (WEB ONLY)  Publication year： Jun. 2017 
JST Material Number： U1085A  ISSN： 1465-3621  Document type： Article
Article type： 原著論文  Country of issue： United Kingdom (GBR)  Language： ENGLISH (EN)

Thesaurus term： human(primates) ,...
Semi thesaurus term： *Pegylated liposomal doxorubicin

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=17A1800784&from=J-GLOBAL&jstjournalNo=U1085A") }}

JST classification (2)： Tumors(=neoplasms)of female genitalia and fetus  (GS04000K) ,  Drug therapy(=pharmacotherapy)for tumors  (GE03032C)

Reference (14)：

• Heintz AP, Odicino F, Maisonneuve P, et al. Carcinoma of the ovary. FIGO 26th annual report on the results of treatment in gynecological cancer. Int J Gynaecol Obstet 2006;95 (Suppl 1):S161-92.
• McGuire WP, Hoskins WJ, Brady MF, et al. Cyclophosphamide and cisplatin compered with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer. New Engl J Med 1996;334:1-6.
• Ferrero JM, Weber B, Geary JF, Lepille D, et al. Second-line chemotherapy with pegylated liposomal doxorubicin and carboplatin is highly effective in patients with advanced ovarian cancer in late relapse: a GINECO phase II trial. Ann Oncol 2007;18:263-8.
• Mahner S, Meier W, du Bois A, et al. Carboplatin and pegylated liposomal doxorubicin versus carboplatin and paclitaxel in very platinum-sensitive ovarian cancer patients: results from a subset analysis of the CALYPSO phase III trial. Br J Cancer 2012;107:588-91.
• Pfisterer J, Plante M, Vergote I, et al. Gemcitabine plus carboplatin compared with carboplatin in patients with platinum-sensitive recurrent ovarian cancer: an intergroup trial of the AGO-OVAR, the NCIC CTG, and the EORTC GCG. J Clin Oncol 2006;24:4699-4707.

Terms in the title (3)： 分子標的療法 ,  卵巣癌 ,  予後